By admin
The Food and Drug Administration (FDA) on Thursday authorized a third dose of Pfizer-BioNTech’s COVID-19 vaccine for older adults and high-risk individuals. The move comes after the Centers for Disease Control and Prevention (CDC) advisory committee recommended the booster for those groups on Sept. 23.